New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Dare Bioscience, Inc. (DARE) vs Lexaria Bioscience Corp. (LEXX)
- Dare Bioscience, Inc. DARE 0.41 −8.89%
- Lexaria Bioscience Corp. LEXX 4.03 −10.24%
Dare Bioscience, Inc. and Lexaria Bioscience Corp. are both Biotechnology companies. Dare Bioscience, Inc. and Lexaria Bioscience Corp. are of similar size ($9.5M and $8.9M). Dare Bioscience, Inc. grew revenue faster over the last twelve months: 2,571.6% against 52.0%. Dare Bioscience, Inc. has the higher net margin (−749.8% vs −1,686.1%) and the higher return on invested capital (0.00% vs −662.6%). Across the 15 metrics below, Lexaria Bioscience Corp. leads on 8 and Dare Bioscience, Inc. on 7.
Valuation
Profitability
| Metric | DARE | LEXX | Biotechnology median |
|---|---|---|---|
| Gross margin | 47.37% | 99.62% | 70.18% |
| Operating margin | (746.14%) | (1,683.06%) | 0.00% |
| Net margin | (749.83%) | (1,686.05%) | 0.00% |
| Free cash flow margin | — | (1,494.56%) | 0.00% |
| Return on equity | (407.13%) | (162.60%) | (51.58%) |
| Return on assets | (40.05%) | (134.20%) | (45.91%) |
| Return on invested capital | 0.00% | (662.56%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack